Price Chart

Profile

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
URL https://www.palatin.com
Investor Relations URL http://www.palatin.com/investors/overview/
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
URL https://www.palatin.com
Investor Relations URL http://www.palatin.com/investors/overview/
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A